Global Nuclear Medicine Market Growth of 8.34% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: Cardinal Health, Digirad, GE Healthcare - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Nuclear Medicine Market 2016-2020" report to their offering.

The global nuclear medicine market is forecast to grow at a CAGR of 8.34% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global nuclear medicine market for 2016-2020. To calculate the market size, the report considers the use revenue generated from the sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and therapeutic purposes.

The report, Global Nuclear Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts.

Questions Answered:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned Include:

  • Cardinal Health
  • Digirad
  • GE Healthcare
  • Lantheus Medical Imaging
  • Philips Healthcare
  • ABT Molecular Imaging
  • Advanced Accelerator Applications
  • AGFA Healthcare
  • Algeta
  • Astellas Pharma
  • Bayer
  • Navidea Biopharmaceuticals
  • Nordion
  • Piramal Imaging
  • Positron Pharmaceutical Company
  • RadioMedix
  • SHINE Medical Technologies
  • Toshiba Medical Systems
  • Triad Isotopes
  • Voxel

Report Structure:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by product

PART 07: Market segmentation by application

PART 08: Market segmentation by end-user

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendors

PART 17: Appendix

PART 18: About the Author

For more information visit http://www.researchandmarkets.com/research/595nts/global_nuclear

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Nuclear Medicine and Radiopharmacology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Nuclear Medicine and Radiopharmacology